Categories
REMDESIVIR – TO BE PROVIDED TO PATIENTS FIRST OR PATENTED FIRST ?
Written By: Rutambhara Nayak Even in a situation of hue and cry, there was a silent race going on between major pharmaceutical companies, researchers and scientists to develop a cure against the deadly corona virus. Every drug house was determined to find a solution that could save the world and in return, the inventor would be a […]
Read more
Alexa- The New Age Emotional Assistant
Written By: Panktee Trivedi Amazon has undoubtedly become a household name in the field of e-commerce services. Although it became a pioneer in the e-commerce sector, it did not limit its reach and had ever since evolved by venturing into different areas such as Consumer Electronics, Cloud Storage, Goods & Services, Digital Media, etc. One […]
Read more
Pfizer loses patent infringement case against Actavis in UK
Written By: Harun Shaikh Before going to the long run patent infringement case, let’s understand first, what is second medical use claims and what is skinny labels in the pharmaceutical area. A different field of use of a known molecule can be subject to Patent Protection, this type of patent is called a second medical […]
Read more
The Cause and Effect of Patent Trolling
Written By: Shilpa Chaudhury The main idea behind granting Patent Protection is safeguarding the labor invested by someone in coming up with a new invention. The protection provides a monopoly to the applicant and also encourages others to come up with new inventions. Patent Protection is beneficial for business entities as they commercialize the patents […]
Read more
AstraZeneca and Dr. Reddy’s Laboratories are back with a Patent Suit
Written by: Stuti Raibagkar It seems that these two companies are not tired of filing lawsuits against each other. After a huge battle over colour of Nexium generic (a drug used to deal with heartburns and gastric ulcers), the companies are back again with one more patent suit. But this time it looks like Dr. […]
Read more
Dr. Reddy and Eli Lilly- a Patent Tussle over Alimta
Written By: Stuti Raibagkar An Indian multinational pharmaceutical company- Dr. Reddy’s Lab (DRL) has lost a legal battle with Eli Lilly and Company- a global pharmaceutical company headquartered in Indianapolis, Indiana. The battle is revolving around Alimta (pemetrexed for injection), a drug used for treatment of various types of cancer, in USA. A U.S. court […]
Read more
16192 Coastal Highway, Lewes, Delaware 19958, USA